Tumor-specific CD4(+) T cells maintain effector and memory tumor-specific CD8(+) T cells

Immunotherapies that augment antitumor T cells have had recent success for treating patients with cancer. Here we examined whether tumor-specific CD4(+) T cells enhance CD8(+) T-cell adoptive immunotherapy in a lymphopenic environment. Our model employed physiological doses of tyrosinase-related pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Church, Sarah E, Jensen, Shawn M, Antony, Paul A, Restifo, Nicholas P, Fox, Bernard A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Cellular Immune Response
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283993/
https://www.ncbi.nlm.nih.gov/pubmed/24114780
http://dx.doi.org/10.1002/eji.201343718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283993/
https://www.ncbi.nlm.nih.gov/pubmed/24114780
http://dx.doi.org/10.1002/eji.201343718

Ejemplares similares